Puressentiel Respiratory Decongestant Nasal Spray
Puressentiel Respiratory Decongestant Nasal Spray, NPN 80062939: natural health product licensed in Canada. Medicinal ingredients: Sodium chloride.
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Sodium chloride Source : Chlorure de sodium | 1.04 % |
Non-medicinal ingredients
Eau, Huile essentielle de fleur de Pelargonium Graveolens, Alcool, Huile essentielle de feuilles de Cinnamomum camphora, Gomme de xanthane, Citrus Limon (Lemon) Juice, Huile essentielle de feuille de Melaleuca viridiflora, Eau de Rosmarinus Officinalis (romarin), Glycérine, Propolis, Huile essentielle de feuille/tige d'Eucalyptus Radiata, Extrait de fleur/feuille/tige d'Echinacea purpurea
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 2 Pulvérisateur | minimum: 3 Tous les jours ; maximum: 5 Tous les jours |
Uses authorised in Canada
Used temporarily as an adjunct in the treatment of common cold and allergic rhinitis. Temporarily relieve symptoms such as nasal irritation and congestion associated with cold, sinusitis by moisturizing and improving mucociliary clearance.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Cautions and Warnings
Keep out of reach of children. For use in Adults - 18 years and over only. Do not swallow. Do not share your device with anyone else. If you experience any discomfort, discontinue using this product and consult a health care practitioner. Consult a health care practitioner if there is no improvement after you have tried to clear the nose, if the discharge is persistently thick and yellow or green, if the skin at the base of the nostrils becomes raw or crusted, if there are other signs or symptoms of illness such as fever or ear infection. Do not rinse if nasal passage is completely blocked or if you have an ear infection or blocked ears. Nasal burning, irritation and nausea are known to occur with hypertonic solution, in which case, discontinue use.
- Contra-Indications
If you are pregnant or breastfeeding do not use this product.
- Known Adverse Reactions
If you experience nausea, dizziness, headache or allergic reactions discontinue use.
Product record
- Licence holder
- Laboratoire Puressentiel
- NPN or DIN-HM
- 80062939
- Status
- Active licence
- Licence date
- 23 July 2015
- Revision date
- 24 November 2020
- Form
- Vaporisateur
- Route of administration
- Nasale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80062939
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Puressentiel Respiratory Decongestant Nasal Spray (Laboratoire Puressentiel): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80062939-puressentiel-respiratory-decongestant-nasal-spray, updated 24 November 2020.